Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Azenta, Inc.AZTA · Entity 4724 | SVP, GM Life Science Products | January 31, 2024 | August 02, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Azenta, Inc.
Report date January 31, 2024 · Filed August 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 31,438 |
Reported balance
After 2024-01-31 transaction · row 1
1 source rowRow 1 · 2024-01-31 · Grant · Acquired 151 · Balance 31,438 F1: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act |
Filing footnotes · ownership attribution and instrument terms
F1: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2024 Filed Feb 2, 2024 21:10 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon | 324 | $39.41 | $12,768.84 |
DisclosureSEC source: 0000950170-24-010487 · ownership.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,287 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| January 31, 2024 Filed Aug 2, 2024 20:05 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon | 151 | $53.01 | $8,004.51 |
DisclosureSEC source: 0000950170-24-089937 · ownership.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,438 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 21:10 UTC | Azenta, Inc. AZTA · Entity 4724 | Disposition to issuerCommon | 5,175 | $56.60 | $292,905.00 |
DisclosureSEC source: 0001209191-23-057596 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,788 Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:12 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 4,582 | $54.57 | $250,039.74 |
DisclosureSEC source: 0001209191-23-055724 · doc4.xml · nonDerivative · entry 3 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,963 F3 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:12 UTC | Azenta, Inc. AZTA · Entity 4724 | Disposition to issuerCommon Stock | 2,946 | $53.81 | $158,524.26 |
DisclosureSEC source: 0001209191-23-055724 · doc4.xml · nonDerivative · entry 2 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,381 F2 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2023 of 4,107 performance stock units and 2,755 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:12 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 4,107 | $54.13 | $222,311.91 |
DisclosureSEC source: 0001209191-23-055724 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,327 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 13, 2020, of which one-third was determined to be earned at 150% and converted into restricted stock units which vested on November 15, 2023. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:10 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 7,400 | $55.00 | $407,000.00 |
DisclosureSEC source: 0001209191-23-045615 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,220 F1 · price: Represents the weighted average price for shares sold on August 10, 2023 at a range between $55.00 and $55.01. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 20:10 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 121 | $39.98 | $4,837.58 |
DisclosureSEC source: 0001209191-23-043948 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,620 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:08 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 265 | $46.92 | $12,433.80 |
DisclosureSEC source: 0001209191-23-006189 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,499 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:26 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 3,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058147 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,234 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:20 UTC | Azenta, Inc. AZTA · Entity 4724 | Tax withholdingCommon Stock | 5,838 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057543 · doc4.xml · nonDerivative · entry 2 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,456 F2 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 11,077 performance stock units and 2,505 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:20 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 11,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057543 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,294 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 11, 2019, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2022. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 22:29 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 285 | $69.29 | $19,747.65 |
DisclosureSEC source: 0001209191-22-006463 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,217 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 21:15 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 6,490 | $119.03 | $772,504.70 |
DisclosureSEC source: 0001209191-21-065795 · doc4.xml · nonDerivative · entry 3 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,932 F4 · price: Represents the weighted average price for shares sold at a range between $119.00 and $119.04. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:15 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 1,549 | $119.27 | $184,749.23 |
DisclosureSEC source: 0001209191-21-065795 · doc4.xml · nonDerivative · entry 2 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,422 F3 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2021 of 3,676 restricted stock units from three grants held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 16, 2021 and November 17, 2021 at a range between $114.73 and $121.43. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:15 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 7,329 | $119.27 | $874,129.83 |
DisclosureSEC source: 0001209191-21-065795 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,971 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2021 of 17,354 performance-based units held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 16, 2021 and November 17, 2021 at a range between $114.73 and $121.43. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:25 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 1,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065102 · doc4.xml · nonDerivative · entry 2 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,677 F2 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2022. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:25 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 17,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065102 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,929 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 29, 2018, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2021. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| July 31, 2021 Filed Nov 17, 2021 21:25 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon | 221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065102 · doc4.xml · nonDerivative · entry 4 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,300 F3 · shares: Purchase by Reporting Person under the Brooks Automation, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| January 31, 2021 Filed Nov 17, 2021 21:25 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065102 · doc4.xml · nonDerivative · entry 3 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,079 F3 · shares: Purchase by Reporting Person under the Brooks Automation, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 23:02 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 1,733 | $69.62 | $120,651.46 |
DisclosureSEC source: 0001209191-20-059752 · doc4.xml · nonDerivative · entry 2 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,575 F3 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2020 of 4,091 restricted stock units from three grants held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 16, 2020 and November 18, 2020 at a range between $68.13 and $71.23. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 23:02 UTC | Azenta, Inc. BRKS · Entity 4724 | SaleCommon Stock | 4,757 | $69.62 | $331,182.34 |
DisclosureSEC source: 0001209191-20-059752 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,308 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2020 of 11,947 performance-based units held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 16, 2020 and November 18, 2020 at a range between $68.13 and $71.23. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 23:11 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 2,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058857 · doc4.xml · nonDerivative · entry 2 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,065 F2 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2021. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 23:11 UTC | Azenta, Inc. BRKS · Entity 4724 | GrantCommon Stock | 11,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058857 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM BLS-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,328 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 8, 2017, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2020. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.